Invention Grant
- Patent Title: Treatment of autoimmune disorders with CD154 antibodies
-
Application No.: US17361393Application Date: 2021-06-29
-
Publication No.: US11884737B2Publication Date: 2024-01-30
- Inventor: Ruth Oliver , Miren Zamacona
- Applicant: UCB BIOPHARMA SRL , BIOGEN MA INC.
- Applicant Address: BE MA Brussels
- Assignee: UCB BIOPHARMA SRL,BIOGEN MA INC.
- Current Assignee: UCB BIOPHARMA SRL,BIOGEN MA INC.
- Current Assignee Address: BE Brussels; US MA Cambridge
- Agency: SALIWANCHIK, LLOYD & EISENSCHENK
- Priority: GB 01613 2015.01.30
- Main IPC: C07K16/02
- IPC: C07K16/02 ; A61K39/395 ; A61P37/06 ; C07K16/28 ; A61K39/00
Abstract:
The present invention relates to a method of treating an autoimmune or inflammatory disease or a neurodegenerative disease with an antibody to CD154.
Public/Granted literature
- US20210324095A1 TREATMENT OF AUTOIMMUNE DISORDERS WITH CD154 ANTIBODIES Public/Granted day:2021-10-21
Information query
